Literature DB >> 33772001

The oncogene AAMDC links PI3K-AKT-mTOR signaling with metabolic reprograming in estrogen receptor-positive breast cancer.

Emily Golden1,2, Rabab Rashwan1,2,3, Eleanor A Woodward1,2, Agustin Sgro1,2,4, Edina Wang1,2, Anabel Sorolla1,2, Charlene Waryah1,2, Wan Jun Tie1,2, Elisabet Cuyàs1,5,6, Magdalena Ratajska7,8,9, Iwona Kardaś7,10, Piotr Kozlowski11, Elizabeth K M Johnstone2,12,13, Heng B See2,12,13, Ciara Duffy1,2,4, Jeremy Parry14, Kim A Lagerborg15, Piotr Czapiewski16,17, Javier A Menendez5,6, Adam Gorczyński16, Bartosz Wasag7,10, Kevin D G Pfleger2,12,13,18, Christina Curtis19, Bum-Kyu Lee20, Jonghwan Kim21, Joseph Cursons22, Nathan J Pavlos8,23, Wojciech Biernat16, Mohit Jain15, Andrew J Woo2,24, Andrew Redfern25, Pilar Blancafort26,27,28,29.   

Abstract

Adipogenesis associated Mth938 domain containing (AAMDC) represents an uncharacterized oncogene amplified in aggressive estrogen receptor-positive breast cancers. We uncover that AAMDC regulates the expression of several metabolic enzymes involved in the one-carbon folate and methionine cycles, and lipid metabolism. We show that AAMDC controls PI3K-AKT-mTOR signaling, regulating the translation of ATF4 and MYC and modulating the transcriptional activity of AAMDC-dependent promoters. High AAMDC expression is associated with sensitization to dactolisib and everolimus, and these PI3K-mTOR inhibitors exhibit synergistic interactions with anti-estrogens in IntClust2 models. Ectopic AAMDC expression is sufficient to activate AKT signaling, resulting in estrogen-independent tumor growth. Thus, AAMDC-overexpressing tumors may be sensitive to PI3K-mTORC1 blockers in combination with anti-estrogens. Lastly, we provide evidence that AAMDC can interact with the RabGTPase-activating protein RabGAP1L, and that AAMDC, RabGAP1L, and Rab7a colocalize in endolysosomes. The discovery of the RabGAP1L-AAMDC assembly platform provides insights for the design of selective blockers to target malignancies having the AAMDC amplification.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33772001     DOI: 10.1038/s41467-021-22101-7

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  60 in total

1.  "Spot 14" protein functions at the pretranslational level in the regulation of hepatic metabolism by thyroid hormone and glucose.

Authors:  S B Brown; M Maloney; W B Kinlaw
Journal:  J Biol Chem       Date:  1997-01-24       Impact factor: 5.157

2.  RSF1 is a positive regulator of NF-κB-induced gene expression required for ovarian cancer chemoresistance.

Authors:  Yeong-In Yang; Ji-Hye Ahn; Kyung-Tae Lee; Ie-Ming Shih; Jung-Hye Choi
Journal:  Cancer Res       Date:  2014-02-24       Impact factor: 12.701

3.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Phenotypic and genotypic spectrum of congenital disorders of glycosylation type I and type II.

Authors:  Amal Al Teneiji; Theodora U J Bruun; Sarah Sidky; Dawn Cordeiro; Ronald D Cohn; Roberto Mendoza-Londono; Mahendranath Moharir; Julian Raiman; Komudi Siriwardena; Lianna Kyriakopoulou; Saadet Mercimek-Mahmutoglu
Journal:  Mol Genet Metab       Date:  2017-01-03       Impact factor: 4.797

5.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

6.  Supervised risk predictor of breast cancer based on intrinsic subtypes.

Authors:  Joel S Parker; Michael Mullins; Maggie C U Cheang; Samuel Leung; David Voduc; Tammi Vickery; Sherri Davies; Christiane Fauron; Xiaping He; Zhiyuan Hu; John F Quackenbush; Inge J Stijleman; Juan Palazzo; J S Marron; Andrew B Nobel; Elaine Mardis; Torsten O Nielsen; Matthew J Ellis; Charles M Perou; Philip S Bernard
Journal:  J Clin Oncol       Date:  2009-02-09       Impact factor: 44.544

7.  Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.

Authors:  Joseph A Sparano; Robert J Gray; Della F Makower; Kathleen I Pritchard; Kathy S Albain; Daniel F Hayes; Charles E Geyer; Elizabeth C Dees; Matthew P Goetz; John A Olson; Tracy Lively; Sunil S Badve; Thomas J Saphner; Lynne I Wagner; Timothy J Whelan; Matthew J Ellis; Soonmyung Paik; William C Wood; Peter M Ravdin; Maccon M Keane; Henry L Gomez Moreno; Pavan S Reddy; Timothy F Goggins; Ingrid A Mayer; Adam M Brufsky; Deborah L Toppmeyer; Virginia G Kaklamani; Jeffrey L Berenberg; Jeffrey Abrams; George W Sledge
Journal:  N Engl J Med       Date:  2018-06-03       Impact factor: 91.245

8.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups.

Authors:  Christina Curtis; Sohrab P Shah; Suet-Feung Chin; Gulisa Turashvili; Oscar M Rueda; Mark J Dunning; Doug Speed; Andy G Lynch; Shamith Samarajiwa; Yinyin Yuan; Stefan Gräf; Gavin Ha; Gholamreza Haffari; Ali Bashashati; Roslin Russell; Steven McKinney; Anita Langerød; Andrew Green; Elena Provenzano; Gordon Wishart; Sarah Pinder; Peter Watson; Florian Markowetz; Leigh Murphy; Ian Ellis; Arnie Purushotham; Anne-Lise Børresen-Dale; James D Brenton; Simon Tavaré; Carlos Caldas; Samuel Aparicio
Journal:  Nature       Date:  2012-04-18       Impact factor: 49.962

9.  Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.

Authors:  A Ghosh; S Awasthi; J R Peterson; A W Hamburger
Journal:  Br J Cancer       Date:  2013-01-29       Impact factor: 7.640

10.  In vitro characterization of mitochondrial function and structure in rat and human cells with a deficiency of the NADH: ubiquinone oxidoreductase Ndufc2 subunit.

Authors:  Salvatore Raffa; Cristina Scrofani; Sabatino Valente; Andrea Micaloni; Maurizio Forte; Franca Bianchi; Roberta Coluccia; Aron M Geurts; Sebastiano Sciarretta; Massimo Volpe; Maria Rosaria Torrisi; Speranza Rubattu
Journal:  Hum Mol Genet       Date:  2017-12-01       Impact factor: 6.150

View more
  3 in total

1.  TBC1D18 is a Rab5-GAP that coordinates endosome maturation together with Mon1.

Authors:  Shu Hiragi; Takahide Matsui; Yuriko Sakamaki; Mitsunori Fukuda
Journal:  J Cell Biol       Date:  2022-10-05       Impact factor: 8.077

2.  Association Between SNPs in the One-Carbon Metabolism Pathway and the Risk of Female Breast Cancer in a Chinese Population.

Authors:  Xuhong Wang; Mengqiu Xiong; Bei Pan; William C S Cho; Jin Zhou; Shukui Wang; Bangshun He
Journal:  Pharmgenomics Pers Med       Date:  2022-01-11

3.  Restriction factor screening identifies RABGAP1L-mediated disruption of endocytosis as a host antiviral defense.

Authors:  Sonja Fernbach; Eva E Spieler; Idoia Busnadiego; Umut Karakus; Anouk Lkharrazi; Silke Stertz; Benjamin G Hale
Journal:  Cell Rep       Date:  2022-03-22       Impact factor: 9.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.